© BloombergVials of the Pfizer-BioNTech Covid-19 vaccine in a box at Kanto Rosai Hospital in Kawasaki, Kanagawa Prefecture, Japan, on Thursday, March 4, 2021. Japanese Prime Minister Yoshihide Suga said the virus emergency in the Tokyo region now set to expire on March 7 may need to be extended for another two weeks, as he seeks to further rein in the pace of infections.
(Bloomberg) -- The Australian government said it has secured an additional 20 million doses of the Pfizer vaccine, amid concerns about blood clotting associated with AstraZeneca Plc's Covid-19 shot.
Prime Minister Scott Morrison said the extra supplies meant Australia would have access to 40 million Pfizer doses this year.
Australia Avoids AstraZeneca Shot for Under 50s on Clot Risk
The government is guiding against giving the AstraZeneca shot to people under the age of 50 following warnings of a link to a rare type of blood clot by the European Medicines Agency.
Locally made AstraZeneca jabs form the backbone of Australia's vaccination effort and the new guidance has heightened concerns that the rollout won't be completed this year. About 1 million people in the nation of 25.8 million have received a first dose. The main opposition Labor party says that falls some 3 million short of the government's promised timeline.
Health Minister Greg Hunt said that, including AstraZeneca shots, Pfizer, Novavax and the Covax facility, Australia has a total available pool of 170 million doses.
(Updates with vaccine rollout concerns)
For more articles like this, please visit us at bloomberg.com
©2021 Bloomberg L.P.